https://www.selleckchem.com/pr....oducts/crenolanib-cp
78.1%; p0.001), less often white (77.2% vs. 82.0%; p0.001), less often had prior opioid use (20.1% vs. 28.1%; p0.001), and more often underwent hysterectomy (91.1% vs. 55.7%; p0.001). After PSM, there were no significant differences between cohorts in baseline characteristics. Matched post-ERAS patients were prescribed fewer opioid pills (17.4 pills vs. 22.0 pills; p0.001) and lower OMEs (129.4 mg vs. 167.6 mg; p0.001) than pre-ERAS patients. Sensitivity analyses confirmed these findings [Open (18.8
Curtir
Comentario
Compartilhar
